Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 6 → 7·14:54, 29 Jul 2025
Difference between revision 6 and revision 7 of Qingdao Saber Technology Pharmaceutical. 5 lines changed; the page grew by 516 bytes.
| Revision 6 — 11:55, 17 Jul 2025 CiteBot (talk) bot: add supplier category 4,833 bytes +898 | Revision 7 — 14:54, 29 Jul 2025 BlindSampleBrid (talk) add the see-also to the certificate-of-analysis article 5,349 bytes +516 | ||
|---|---|---|---|
| 1 | {{Infobox organisation | 1 | {{Infobox organisation |
| 2 | | name = Qingdao Saber Technology Pharmaceutical | 2 | | name = Qingdao Saber Technology Pharmaceutical |
| + | 3 | | image = facility.svg | |
| + | 4 | | caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| 3 | | Legal name = Qingdao Saber Technology Pharmaceutical | 5 | | Legal name = Qingdao Saber Technology Pharmaceutical |
| 4 | | Trading name = QST | 6 | | Trading name = QST |
| ⋮ | ⋮ | ||
| 28 | Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity and appearance; water determinations are issued against a named lot on request.{{r|reports}} Packaging descriptions have been conventional, with a gel pack on the temperature-sensitive lines and a desiccant sachet inside the secondary container. | 30 | Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity and appearance; water determinations are issued against a named lot on request.{{r|reports}} Packaging descriptions have been conventional, with a gel pack on the temperature-sensitive lines and a desiccant sachet inside the secondary container. |
| 29 | 31 | ||
| + | 32 | No certification claim has been corroborated, and the organisation's own statements about capability are self-published.{{r|selfpub,gmp}} | |
| + | 33 | ||
| 30 | == References == | 34 | == References == |
| 31 | {{reflist}} | 35 | {{reflist}} |
| ⋮ | ⋮ | ||
| 35 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 39 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 36 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 40 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 41 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | |
| 37 | 42 | ||
| 38 | {{DEFAULTSORT:Qingdao Saber Technology Pharmaceutical}} | 43 | {{DEFAULTSORT:Qingdao Saber Technology Pharmaceutical}} |